A. K. Pal, “Real world evidence of effectiveness and safety of an oral formulation containing un-denatured type-II collagen 40 mg and aflapin 100 mg (HAPID®) in the management of osteoarthritis of knee: findings of a prospective, multi-center, observational study”, Int J Res Orthop, vol. 9, no. 1, pp. 58–65, Dec. 2022.